| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 11/17/2010 | EP2251424A1 Antigenic neisserial peptides |
| 11/17/2010 | EP2251419A1 Porcine reproductive and respiratory syndrome vaccine, based on isolate JA-142 |
| 11/17/2010 | EP2251418A1 Mature dendritic cell compositions and methods for culturing same |
| 11/17/2010 | EP2251357A1 Camelidae single domain antibodies VHH directed against epidermal growth factor receptor and uses therefor |
| 11/17/2010 | EP2251355A1 Treatment with anti-VEGF antibodies |
| 11/17/2010 | EP2251353A1 Homogeneous preparations of IL-28 and IL-29 |
| 11/17/2010 | EP2251352A1 Homogeneous preparations of IL-28 and IL-29 |
| 11/17/2010 | EP2251350A2 RORalpha promoting the induction of Bmal1 |
| 11/17/2010 | EP2251040A1 Use of a melanoma differentiation associated gene (mda 7) for reversing a cancerous phenotype |
| 11/17/2010 | EP2251037A1 KIM-1 antibodies for treatment of TH1/TH2-mediated conditions |
| 11/17/2010 | EP2251036A1 Chimeric flavivirus vaccines |
| 11/17/2010 | EP2251035A2 New virulence factors of Streptococcus pneumoniae |
| 11/17/2010 | EP2251034A1 Chimeric Newcastle Disease viruses presenting non-native surface proteins and uses thereof |
| 11/17/2010 | EP2251026A1 Methods and compositions for inhibiting immunoglobulin-mediated reperfusion injury |
| 11/17/2010 | EP2250887A2 Use of non-antibacterial tetracycline analog CMT-1002 and formulations thereof for the treatment of bacterial exotoxins |
| 11/17/2010 | EP2250269A2 Attenuated recombinant alphaviruses incapable of replicating in mosquitoes and uses thereof |
| 11/17/2010 | EP2250201A1 Membrane transporter napi2b (slc34a2) epitope for antibody therapy, antibodies directed thereto, and target for cancer therapy |
| 11/17/2010 | EP2250192A1 Protein or glycoprotein from haliotis midae and its use as an immunotherapy agent |
| 11/17/2010 | EP2250189A1 Glycopeptides and methods of making and using them |
| 11/17/2010 | EP2249865A2 Breaking immunological tolerance with a genetically encoded unnatural amino acid |
| 11/17/2010 | EP2249864A2 Strategies to prevent and/or treat immune resuponses to soluble allofactors |
| 11/17/2010 | EP2249846A2 Preparation comprising mycobacterium bovis bcg killed by extended freeze drying (efd) for preventing or treating rheumatoid arthritis. |
| 11/17/2010 | EP2249835A1 Methods using immunomodulatory compounds for modulating level of cd59 |
| 11/17/2010 | EP2249827A1 Use of picoplatin and cetuximab to treat colorectal cancer |
| 11/17/2010 | EP2249809A1 Powdered protein compositions and methods of making same |
| 11/17/2010 | EP2249661A2 Products and methods to prevent infection |
| 11/17/2010 | EP2249645A1 Dna vaccines and methods for the prevention of transplantation rejection |
| 11/17/2010 | EP1804836B1 Methods of diagnosing and treating complications of pregnancy |
| 11/17/2010 | EP1789084B1 Decreasing potential iatrogenic risks associated with influenza vaccines |
| 11/17/2010 | EP1576182B1 Product quality enhancement in mammalian cell culture processes for protein production |
| 11/17/2010 | EP1565489B1 Internalizing antibodies specific for the RAAG10 cell surface target |
| 11/17/2010 | EP1545597B1 Immunostimulatory compositions and methods of stimulating an immune response |
| 11/17/2010 | EP1506295B1 Muteins of placental growth factor type 1, preparation method and application thereof |
| 11/17/2010 | EP1420821B1 Immunologically significant herpes simplex virus antigens and methods for using same |
| 11/17/2010 | EP1276852B1 Viruses comprising mutated ion channel protein |
| 11/17/2010 | EP1204682B1 Compositions and methods for the treatment of tumors |
| 11/17/2010 | EP1159003B1 Anti-tnf alpha antibodies in therapy of steroid resistant asthma |
| 11/17/2010 | EP0862419B2 Microencapsulated dna for vaccination and gene therapy |
| 11/17/2010 | CN101889026A Il-23 antibodies |
| 11/17/2010 | CN101888856A Antibodies that bind human dendritic and epithelial cell 205 (DEC-205) |
| 11/17/2010 | CN101888855A Cancer remedy containing antibody against peptide encoded by exon-17 of periostin |
| 11/17/2010 | CN101888854A Lentivirus pseudotyped with influenza hemagglutinin and methods of use |
| 11/17/2010 | CN101888853A Use of MVA to treat prostate cancer |
| 11/17/2010 | CN101888852A 癌症疫苗组合物 Cancer vaccine composition |
| 11/17/2010 | CN101886123A Application of vascular endothelial growth factor receptor-2 (VEGFR-2) in temporomandibular joint disturbance |
| 11/17/2010 | CN101886106A Method for extracting collagen peptide from fish scales |
| 11/17/2010 | CN101886084A Codon-optimized H3HA/XJ3-07 gene and nucleic acid vaccine thereof |
| 11/17/2010 | CN101885778A HPV (Human Papilloma Virus) 16 type L2N120E7E6 fusion protein, gene, preparation method and application |
| 11/17/2010 | CN101885770A Fully human antibody capable of specifically bonding CD15 and use thereof |
| 11/17/2010 | CN101885769A Fully human antibody capable of specifically bonding CD4 and use thereof |
| 11/17/2010 | CN101885760A HIV-1gp120 gene consensus sequence optimized by codon and gp120 nucleic acid vaccine |
| 11/17/2010 | CN101885757A Avian influenza hemagglutinin, epitope peptide, monoclonal antibodies for resisting avian influenza hemagglutinin and epitope peptide, and applications of monoclonal antibodies |
| 11/17/2010 | CN101884793A Immune enhanced gene vaccine of hepatitis B virus core antigen and preparation method thereof |
| 11/17/2010 | CN101884792A Immune enhanced gene vaccine of hepatitis B virus surface antigen and preparation method thereof |
| 11/17/2010 | CN101884789A Ctgf as target for the therapy of diabetic nephropathy |
| 11/17/2010 | CN101884788A Traditional Chinese medicine astragalus polysaccharide immunopotentiator |
| 11/17/2010 | CN101884787A Porcine circovirus type 2 subunit vaccine and preparation method thereof |
| 11/17/2010 | CN101884784A Bv8 nucleic acids and polypeptides with mitogenic activity |
| 11/17/2010 | CN101884780A Use of hepcidin as a regulator of iron homeostasis |
| 11/17/2010 | CN101457215B Recombinant porcine pseudorabies virus-porcine propagate and breath complex virus-porcine circovirus genetic engineering strain and application |
| 11/17/2010 | CN101402942B PolyLyse-HSP70 fusion protein film modified intestinal cancer cytoma vaccine and method of producing the same |
| 11/17/2010 | CN101307109B Mouse-anti-human T lymphocyte CD3 surface antigen monoclonal antibodies, method for preparing same and use |
| 11/17/2010 | CN101052412B Amebiasis subunit vaccine |
| 11/16/2010 | US7834166 Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics |
| 11/16/2010 | US7834156 Monoclonal antibody comprising cytotoxic fusion for use in treatment of cell proliferative disorers |
| 11/16/2010 | US7834155 using the conjugates in the inhibition of cell growth; cancer; monoclonal antibody or epitope-binding fragment thereof, that recognizes and binds the CA6 glycotope |
| 11/16/2010 | US7834154 Angiogenesis inhibition |
| 11/16/2010 | US7834151 Fibrinogen binding protein for use in diagnosis, prevention and treatment of Staphylococcal infection; bactericides; wound healing agents |
| 11/16/2010 | US7833993 Bisphosphate, bis-quaternary ammonium or bis-amine salt compounds that bind a Toll-like receptor; use desensitizing allergies, treating autoimmune diseases and inflammatory diseases, ischemia |
| 11/16/2010 | US7833976 administering an antitumor agent containing a combination of an alpha v beta 3 angiogenisis antagonist and an anti-tumor immunotherapeutic agent, which is a fusion protein of a cytokine IL-2 and an Ig heavy chain that immunoreacts with a tumor associated antigen target; drug target |
| 11/16/2010 | US7833963 For use as an anticancer agent and an immunosuppressive agent |
| 11/16/2010 | US7833786 Anti-IL-6 antibodies, compositions, methods and uses |
| 11/16/2010 | US7833783 Postweaning multisystemic wasting syndrome and porcine circovirus from pigs |
| 11/16/2010 | US7833780 Viral diagnostic method and well for use in same |
| 11/16/2010 | US7833775 Attenuated for cell proliferation; repair nucleic acids; vaccines against cancer, infections |
| 11/16/2010 | US7833731 A protein utilizing an anti-gold antibody and a gold-binding side which is a part of the anti-gold antibody; used for the detection of a target substance; kits |
| 11/16/2010 | US7833722 Ligands for G protein-coupled receptor protein and use thereof |
| 11/16/2010 | US7833717 Using neisserial surface protein nucleotide sequences as tool in detection, prevention and treatment of microorganismal infection; immunodiagnostics; immunotherapeutics; vaccine development |
| 11/16/2010 | US7833700 Kit for use in lysis and isolation of viral enzymatic polypeptides |
| 11/16/2010 | US7833699 Detection of tuberculosis and infection by Mycobacterium tuberculosis using HBHA |
| 11/16/2010 | US7833538 using an immunostimulatory dinucleotide of formula CpG*, wherein C is a natural or non-natural pyrimidine nucleoside and G* is 7-deazaguanosine; for treating autoimmune disorders, such as autoimmune asthma; allergies |
| 11/16/2010 | US7833537 administering isolated and purified T. suis helminthic parasite preparation free of human bacterial, mycobacterial and viral pathogens; treating inflammatory bowel disease, crohn's disease, and ulcerative colitis, rheumatoid arthritis, type 1 diabetes mellitus, lupus erythematosis, sarcoidosis |
| 11/16/2010 | US7833536 Combating the pathogenic effects of Mycoplasma infection in an animal by administering an effective amount of isolated and purified mycoplasmal L-alpha-glycerophosphate oxidase or an immunogenic fragment thereof, and a pharmaceutically acceptable carrier |
| 11/16/2010 | US7833535 Neuropeptide Y, kyotorphin, calcitonin-gene related peptides bind receptors; Clostridial toxin HN domain translocates toxin light chain across endosome membrane;Clostridial toxin light chain cleaves a neurosecretory protein; HC domain modified to reduce binding to receptors at neuromuscular junction |
| 11/16/2010 | US7833534 polypeptides and fusion proteins containing immunogenic portion of Leishmania antigens; screening library for tandem repeat immunogenic proteins |
| 11/16/2010 | US7833533 Enhanced antiviral activity against foot and mouth disease |
| 11/16/2010 | US7833532 synthetic molecules comprising co-linear T-helper and CTL epitopes; enhanced ability to activate a T cell response to a CD8+ T cell epitope to induce cell mediated immunity against an invading pathogen or tumour cell |
| 11/16/2010 | US7833531 means of delivering the GLP-1 peptide in a sustained manner; obesity related disorders |
| 11/16/2010 | US7833530 Methods of inhibiting the PSGL-1-mediated adhesion and chemokine-mediated migration with PSGL-1-specific antibodies |
| 11/16/2010 | US7833529 secreted tumor necrosis factor receptor polypeptides; modulates B cell activation; inhibiting transmembrane activator and CAML-interactor (TACI)//BCMA ; autoimmune disease; inflammation |
| 11/16/2010 | US7833528 Drug delivery where chemotherapeutic drug is converted to an active drug by a target-tissue-localized complex that comprises an enzyme formed by premixing bispecific monoclonal antibody or bispecific antibody fragment with a hapten-enzyme covalent conjugate |
| 11/16/2010 | US7833527 Methods of treating psoriasis using IL-17 Receptor A antibodies |
| 11/16/2010 | US7833526 Using antisense agents and or immunoglobulins as modulators of cell death; treating cell proliferative and reproductive disorders |
| 11/16/2010 | US7833525 Crystals of whole antibodies and fragments thereof and methods for making and using them |
| 11/16/2010 | US7833521 Admnistering a fusion protein of interferon and albumin or an albumin variant, having a higher plasma stability than unfused interferon; albumin or variant is located either at the N-terminus or C-terminus of the fusion protein, fusion protein retains the therapeutic activity of unfused interferon |
| 11/16/2010 | CA2523216C Recombinant alphavirus vectors |
| 11/16/2010 | CA2428739C Complementing cell lines |
| 11/16/2010 | CA2342609C Adjuvant containing n-formyl methionyl peptides for vaccines |
| 11/16/2010 | CA2333578C Adjuvant and vaccine compositions containing monophosphoryl lipid a |
| 11/16/2010 | CA2283462C Vectors having enhanced expression and methods of making and uses thereof |